Curcumin Stereoisomer, Cis-Trans Curcumin, as a Novel Ligand to A<sub>1</sub> and A<sub>3</sub> Adenosine Receptors
Adenosine receptors (ARs) are being explored to generate non-opioid pain therapeutics. Vanilloid compounds, curcumin, capsaicin, and vanillin possess antinociceptive properties through their interactions with the transient receptor potential channel family. However, their binding with adenosine rece...
Saved in:
Main Authors: | Luke J. Hamilton (Author), Mahesh Pattabiraman (Author), Haizhen A. Zhong (Author), Michaela Walker (Author), Hilary Vaughn (Author), Surabhi Chandra (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Species Differences in Microsomal Metabolism of Xanthine-Derived A<sub>1</sub> Adenosine Receptor Ligands
by: Daniela Schneider, et al.
Published: (2021) -
High Biocompatibility, MRI Enhancement, and Dual Chemo- and Thermal-Therapy of Curcumin-Encapsulated Alginate/Fe<sub>3</sub>O<sub>4</sub> Nanoparticles
by: Xuan-Hai Do, et al.
Published: (2023) -
Curcumin Protects Human Trophoblast HTR8/SVneo Cells from H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Stress by Activating Nrf2 Signaling Pathway
by: Lina Qi, et al.
Published: (2020) -
Tumor Immunotherapy Using A<sub>2A</sub> Adenosine Receptor Antagonists
by: Jinfeng Zhang, et al.
Published: (2020) -
A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
by: Andrea Spinaci, et al.
Published: (2022)